PD-1/PD-L1 axis is involved in the interaction between microglial polarization and glioma

被引:8
作者
Wang, Xi-Peng [1 ,2 ]
Guo, Wei [2 ]
Chen, Ye-Fan [2 ]
Hong, Chen [2 ]
Ji, Juan [2 ]
Zhang, Xi-Yue [2 ]
Dong, Yin-Feng [1 ]
Sun, Xiu-Lan [1 ,2 ]
机构
[1] Nanjing Univ Chinese Med, Nanjing, Peoples R China
[2] Nanjing Med Univ, Dept Pharmacol, Jiangsu Key Lab Neurodegenerat, Nanjing, Peoples R China
关键词
PD-1; PD-L1; Glioma; Microglia; Polarization; PD-L1; EXPRESSION; ACTIVATION; BLOCKADE; RECEPTOR; INHIBITION; PROGNOSIS; NIVOLUMAB; EFFICACY; STAT3;
D O I
10.1016/j.intimp.2024.112074
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The tumor microenvironment plays a vital role in glioblastoma growth and invasion. PD-1 and PD-L1 modulate the immunity in the brain tumor microenvironment. However, the underlying mechanisms remain unclear. In the present study, in vivo and in vitro experiments were conducted to reveal the effects of PD-1/PD-L1 on the crosstalk between microglia and glioma. Results showed that glioma cells secreted PD-L1 to the peritumoral areas, particularly microglia containing highly expressed PD-1. In the early stages of glioma, microglia mainly polarized into the pro-inflammatory subtype (M1). Subsequently, the secreted PD-L1 accumulated and bound to PD-1 on microglia, facilitating their polarization toward the microglial anti-inflammatory (M2) subtype primarily via the STAT3 signaling pathway. The role of PD-1/PD-L1 in M2 polarization of microglia was partially due to PD-1/PD-L1 depletion or application of BMS-1166, a novel inhibitor of PD-1/PD-L1. Consistently, coculturing with microglia promoted glioma cell growth and invasion, and blocking PD-1/PD-L1 significantly suppressed these processes. Our findings reveal that the PD-1/PD-L1 axis engages in the microglial M2 polarization in the glioma microenvironment and promotes tumor growth and invasion.
引用
收藏
页数:12
相关论文
共 63 条
[1]   The Incidence, Correlation with Tumor-Infiltrating Inflammation, and Prognosis of Phosphorylated STAT3 Expression in Human Gliomas [J].
Abou-Ghazal, Mohamed ;
Yang, David S. ;
Qiao, Wei ;
Reina-Ortiz, Chantal ;
Wei, Jun ;
Kong, Ling-Yuan ;
Fuller, Gregory N. ;
Hiraoka, Nobuyoshi ;
Priebe, Waldemar ;
Sawaya, Raymond ;
Heimberger, Amy B. .
CLINICAL CANCER RESEARCH, 2008, 14 (24) :8228-8235
[2]   PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma [J].
Ansell, Stephen M. ;
Lesokhin, Alexander M. ;
Borrello, Ivan ;
Halwani, Ahmad ;
Scott, Emma C. ;
Gutierrez, Martin ;
Schuster, Stephen J. ;
Millenson, Michael M. ;
Cattry, Deepika ;
Freeman, Gordon J. ;
Rodig, Scott J. ;
Chapuy, Bjoern ;
Ligon, Azra H. ;
Zhu, Lili ;
Grosso, Joseph F. ;
Kim, Su Young ;
Timmerman, John M. ;
Shipp, Margaret A. ;
Armand, Philippe .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04) :311-319
[3]   Neuropathological imaging:: in vivo detection of glial activation as a measure of disease and adaptive change in the brain [J].
Banati, RB .
BRITISH MEDICAL BULLETIN, 2003, 65 :121-+
[4]   Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma [J].
Berghoff, Anna Sophie ;
Kiesel, Barbara ;
Widhalm, Georg ;
Rajky, Orsolya ;
Ricken, Gerda ;
Woehrer, Adelheid ;
Dieckmann, Karin ;
Filipits, Martin ;
Brandstetter, Anita ;
Weller, Michael ;
Kurscheid, Sebastian ;
Hegi, Monika E. ;
Zielinski, Christoph C. ;
Marosi, Christine ;
Hainfellner, Johannes A. ;
Preusser, Matthias ;
Wick, Wolfgang .
NEURO-ONCOLOGY, 2015, 17 (08) :1064-1075
[5]   Tumor-associated microenvironment, PD-L1 expression and their relationship with immunotherapy in glioblastoma, IDH-wild type: A comprehensive review with emphasis on the implications for neuropathologists [J].
Broggi, Giuseppe ;
Angelico, Giuseppe ;
Farina, Jessica ;
Tinnirello, Giordana ;
Barresi, Valeria ;
Zanelli, Magda ;
Palicelli, Andrea ;
Certo, Francesco ;
Barbagallo, Giuseppe ;
Magro, Gaetano ;
Caltabiano, Rosario .
PATHOLOGY RESEARCH AND PRACTICE, 2024, 254
[6]   Soluble Programmed Death Receptor Ligands sPD-L1 and sPD-L2 as Liquid Biopsy Markers for Prognosis and Platinum Response in Epithelial Ovarian Cancer [J].
Buderath, Paul ;
Schwich, Esther ;
Jensen, Christina ;
Horn, Peter A. ;
Kimmig, Rainer ;
Kasimir-Bauer, Sabine ;
Rebmann, Vera .
FRONTIERS IN ONCOLOGY, 2019, 9
[7]   Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response [J].
Chen, Gang ;
Huang, Alexander C. ;
Zhang, Wei ;
Zhang, Gao ;
Wu, Min ;
Xu, Wei ;
Yu, Zili ;
Yang, Jiegang ;
Wang, Beike ;
Sun, Honghong ;
Xia, Houfu ;
Man, Qiwen ;
Zhong, Wenqun ;
Antelo, Leonardo F. ;
Wu, Bin ;
Xiong, Xuepeng ;
Liu, Xiaoming ;
Guan, Lei ;
Li, Ting ;
Liu, Shujing ;
Yang, Ruifeng ;
Lu, Youtao ;
Dong, Liyun ;
McGettigan, Suzanne ;
Somasundaram, Rajasekharan ;
Radhakrishnan, Ravi ;
Mills, Gordon ;
Lu, Yiling ;
Kim, Junhyong ;
Chen, Youhai H. ;
Dong, Haidong ;
Zhao, Yifang ;
Karakousis, Giorgos C. ;
Mitchell, Tara C. ;
Schuchter, Lynn M. ;
Herlyn, Meenhard ;
Wherry, E. John ;
Xu, Xiaowei ;
Guo, Wei .
NATURE, 2018, 560 (7718) :382-+
[8]   The Prognostic and Therapeutic Value of PD-L1 in Gliomaa [J].
Chen, Ruo Qiao ;
Liu, Feng ;
Qiu, Xin Yao ;
Chen, Xiao Qian .
FRONTIERS IN PHARMACOLOGY, 2019, 9
[9]   Combination of p38 MAPK inhibitor with PD-L1 antibody effectively prolongs survivals of temozolomide-resistant glioma-bearing mice via reduction of infiltrating glioma-associated macrophages and PD-L1 expression on resident glioma-associated microglia [J].
Dang, Weiqi ;
Xiao, Jingfang ;
Ma, Qinghua ;
Miao, Jingya ;
Cao, Mianfu ;
Chen, Lu ;
Shi, Yu ;
Yao, Xiaohong ;
Yu, Shichang ;
Liu, Xindong ;
Cui, Youhong ;
Zhang, Xia ;
Bian, Xiuwu .
BRAIN TUMOR PATHOLOGY, 2021, 38 (03) :189-200
[10]   The Change of Soluble Programmed Cell Death-Ligand 1 in Glioma Patients Receiving Radiotherapy and Its Impact on Clinical Outcomes [J].
Ding, Xing-Chen ;
Wang, Liang-Liang ;
Zhu, Yu-Fang ;
Li, Yan-Dong ;
Nie, Shu-Lun ;
Yang, Jia ;
Liang, Hua ;
Weichselbaum, Ralph R. ;
Yu, Jin-Ming ;
Hu, Man .
FRONTIERS IN IMMUNOLOGY, 2020, 11